A company called Austin Private Wealth LLC shorted 12,000,000 shares of $DJT via a put option. The filing date is July 12th, the day before the assassination attempt.
They have around $1 Billion in assets under management and this is by far the largest put placed. According to a source the trade represents 6% of total shares and over 16%! of the float of the stock given the fact that Trump owns 60% of the company.
This is a giant bet when you consider their total AUM but wait there’s more…
To make things even more interesting, my source tipped me off with the following two images from their Bloomberg terminal.
The screenshot on the left shows the Put by Austin Private Wealth LLC, that was taken earlier this morning. It shows the 120,000 puts.
As you can see their position is by far the largest, the next closest is Citadel Advisors with 16,770.
Here is where it gets interesting, the screenshot to the right was taken later in the day and poof, Austin Private Wealth LLC is nowhere to be found. Why?
While you are here remember to give me a follow to stay up to date on this investigation.
Also, if you have any more information, my DM’s are open.
Austin Private Wealth amended their filing on 7/16 and removed their put option on TMGT 👀
Another interesting thing about the amendment filed on 7/16 is that it is the only one they have ever had. I searched and their first filing was on 2-12-2020. sec.gov/edgar/browse/?…
Austin Private Wealth released the following statement about the shorted DJT.
“Statement on Incorrect Filing with the SEC
The SEC filing which showed that Austin Private Wealth shorted a large number of shares of Trump Media & Technology Group Corp (DJT) was incorrect and we immediately amended it as soon as we learned of the error.
No client of APW holds, or has ever held, a put on DJT in the quantity initially reported. The correct holding amount was 12 contracts, or 1,200 shares— not 12 million shares, as was filed in error. In submitting the required report for the second quarter of 2024, a multiplier was applied by a third-party vendor that increased the number of the shares by a multiple of 10,000 for all options contracts (not just DJT). We did not catch the error before approving the filing. We filed the report on July 12 to reflect our positions on June 28. We amended it on July 16.”
“We deeply regret this error and the concern it has caused, especially at such a fraught moment for our nation. We are committed to full transparency and maintaining the trust of our clients. As such, we are reviewing our internal procedures and our processes with the third-party vendor that assists with SEC filings to better understand how this happened and avoid similar issues moving forward.”
I see a community notes has been added. The REPORTING DATE was 6/30 and the 13F was FILED on 7/12 as if it makes a difference. Followed by an amendment on 7/16.
Nowhere in that post did I say that the trade was made on 7/12, I was referring to the 13F filing date and even link to it.
That note should be removed, rate it accordingly.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
THREAD 🧵: The Invisible Battlefield of Social Media, how Bots Quietly Own the Narrative
Social media is a warzone, behind the hood there are armies of bots, algorithmic black boxes, and deliberate astroturf campaigns controlling what seems “organic.”
The operative term here is astroturfing: the creation of fake grassroots movements. Bots amplify selected narratives under the guise of popular consensus, drowning out dissent. The public never sees the puppet strings.
Magistrate Judge Teresa Stokes in North Carolina isn’t just on the bench, she’s also listed as co-owner of Pinnacle Recovery Services, a mental health and addiction treatment outfit.
So when defendants get diverted from jail into “treatment,” guess whose business stands to gain?
Seriously, this is huge scandal. This lady let a repeated violent criminal off the hook over a dozen times, released to a facility she co-owns and undoubtedly profits from. He then commits an unspeakable crime that should have never been allowed to happen.
So the calls for RFK Jr. to resign didn’t come out of nowhere. A leaked April 3 “BIO Vaccine Policy Steering Committee” memo shows industry insiders openly plotting to “go to The Hill and lobby that it is time for RFK Jr. to go.”
The memo circulated under BIO, the biotech industry’s lobbying arm, names Novavax, Merck, and allies like AEI, Sen. Bill Cassidy, and even Dr. Oz as part of a coalition to rebrand vaccines as “national security” and box Kennedy out of FDA/CDC policy.
It wasn’t just rhetoric. The memo earmarks half of BIO’s $4M reserve for a new campaign: “Why We Vaccinate.” That campaign launched in DC weeks later, exactly as the memo said. The ad blitz was meant to soften public opinion while Congress got leaned on.
For several decades the U.S. government secretly used its own citizens as human lab rats.
The victims? Cancer patients, children, prisoners, the poor.
The experiments? Injecting plutonium, blasting bodies with radiation, feeding kids radioactive cereal.
Here’s a look…
1945. Oak Ridge, TN. - Patient Zero
Ebb Cade, a Black construction worker, is hospitalized after a car crash.
Instead of setting his broken bones, Army doctors inject him with plutonium.
Then they yank his teeth and bone for study.
The experimenters delayed treatment to harvest radioactive samples from his body but he caught on and fled before they could do more.
You know that new “universal vaccine” that RFK Jr. was just touting?
It’s called BPL-1357 – a beta-propiolactone inactivated, whole-virus “universal influenza” vaccine developed in-house at NIH’s NIAID.
You’ll never guess who is funding its production?
Bill Gates.
BPL-1357 contains four different low-pathogenicity avian influenza A viruses:
•H1N9
•H3N8
•H5N1
•H7N3
Each has a different hemagglutinin (HA) & neuraminidase (NA) subtype.
The Data and Safety Monitoring Board Report on the BPL-1357 Phase 1 Trial:
The National Toxicology Program lists BPL as “reasonably anticipated to be a human carcinogen” citing solid evidence of tumors in multiple rodent species via different exposure routes (dermal, oral, injection).